Cannabis Business Law Updates and Insights by Amundsen Davis: Amundsen Davis

Bill to Reopen U.S. Government Poised to Kill the Multi-Billion Dollar Intoxicating Hemp Products Industry

Darren P. Grady — Fri, 14 Nov 2025 09:00:01 -0500

On November 12, 2025, legislation was enacted to end the longest government shutdown in the history of the U.S. While the government is open and operational, the passage of the reopening bill has sent shockwaves through the hemp industry, and for good reason.

The bill provides funding for the government for the next 10 weeks and also contains three fiscal year appropriations packages. One of those packages is an extensive spending bill for the agriculture industry. The agriculture appropriations package contains language that most industry experts see as a death knell for the U.S. hemp industry.

Marijuana Legalization Cut From Wisconsin Governor’s Proposed Budget

Krissy Atterholt — Thu, 15 May 2025 09:00:02 -0400

Wisconsin Governor Tony Evers took another swing at legalizing cannabis in his proposed 2025-27 budget and struck out. On May 8, 2025, the Wisconsin Legislature’s Joint Finance Committee eliminated marijuana legalization from the governor’s budget proposal. Marijuana regulation was part of the roughly 600 budget provisions eliminated by the committee.

Subject to regulation, legalization under Evers’s proposal and companion bills AB50 and SB45 would have created a medical cannabis program and an adult-use market and permitted residents to cultivate a limited ...

Marijuana Legalization Proposed Again in Wisconsin: Considerations and Potential Opportunities

Krissy Atterholt — Thu, 06 Mar 2025 09:00:03 -0500

Governor Evers takes another swing at legalizing marijuana in Wisconsin. Companion bills AB50 and SB45 would create several avenues to legally obtain marijuana, including through an adult-use market, a medical program, and home grow opportunities.

Essential Considerations for Advertising and Marketing in Ohio's Cannabis Industry

Christopher R. Green — Fri, 27 Sep 2024 09:00:04 -0400

With the recent legalization of recreational (or “adult-use”) cannabis in Ohio and sales becoming legal effective August 6, 2024, the burgeoning industry is met with a mix of excitement and regulatory challenges. As new cannabis businesses emerge, it is crucial to effectively navigate the complex landscape of advertising and marketing within the state.

Economic Opportunities For Cannabis Businesses May Expand Following Rescheduling

Darren P. Grady, Jack Hurst — Thu, 13 Jun 2024 09:00:05 -0400

The U.S. Drug Enforcement Administration’s (DEA) recent recommendation to reschedule marijuana (cannabis) from Schedule I of the Controlled Substances Act (CSA) to Schedule III of the CSA has received praise and criticism on both sides of the aisle and among those in between. The strong likelihood that the DEA’s recommendation will become reality prompts us to consider what is down the pike as a result of this rescheduling, especially for state-legal cannabis businesses. Of particular interest will be the impact of rescheduling on: (1) the federal tax code and the ability to deduct ordinary and necessary business-related expenses, (2) access to traditional banking services, (3) and the opening of interstate commerce. Each ramification is discussed in turn below.

A Major Step Towards Reform: The DEA Recommends Rescheduling Cannabis

Darren P. Grady — Wed, 01 May 2024 09:00:06 -0400

The U.S. Drug Enforcement Administration has announced its intention to reschedule cannabis from a Schedule I to a Schedule III drug, marking a significant shift in federal drug policy. This move, prompted by the Biden Administration's review and supported by various governmental agencies, could reshape how cannabis is treated in the eyes of the law, potentially easing business operations, expanding access to traditional banking services, and fostering medical research.

Historic Cannabis Rescheduling on the Horizon? It's Up to the DEA Now

Darren P. Grady — Thu, 31 Aug 2023 09:00:07 -0400

In October of 2022, the Biden Administration started an official cannabis policy review process, which began with granting pardons to all people convicted of simple cannabis possession under federal law. At the time, this was considered to be the most extensive White House action taken to date on federal drug policy in quite some time. Over the last year, the process shifted to the review of cannabis policy by certain critical governmental agencies, including the Food & Drug Administration (FDA). The FDA conducted its review, and then provided comment to the National Institute on Drug Abuse (NIDA) and Department of Health and Human Services (HHS).

FDA Issues First Ever Guidance for Research of Psychedelics

Darren P. Grady — Thu, 03 Aug 2023 09:00:08 -0400

Earlier this summer, the Food & Drug Administration (FDA) issued draft guidance for those researching the use of psychedelics to treat certain serious medical conditions including major depressive disorder, PTSD, and substance use disorders. This is the very first time the FDA has provided guidance to the ever growing list of entities conducting research on these controlled substances for the purpose of setting up clinical trials.

Movement on the SAFE Banking Act? The Senate is Talking the Talk, but Not Ready to Walk the Walk

Darren P. Grady — Fri, 19 May 2023 09:00:09 -0400

Earlier this month, the U.S. Senate Banking Committee met to discuss the SAFE Banking Act, a critical piece of proposed legislation that would make it easier for the cannabis industry to secure and utilize much needed banking services. Overall, the fact that the Act has warranted extensive discussion by legislators is promising, but passage of the Act as currently styled still seems relatively far off. The meeting, which was entitled “Examining Cannabis Banking Challenges of Small Businesses and Workers,” heard testimony from bipartisan lawmakers, including the Senators who reintroduced the bill (Jeff Merkley and Steve Daines).

The Federal Government & CBD – What the FDA is Happening?

Darren P. Grady — Thu, 26 Jan 2023 09:00:10 -0500

Many of us following the ever expanding cannabis industry in the United States have seen more and more CBD-infused food and drink products hitting the market and becoming readily available for consumers.